Akebia Therapeutics Inc (NASDAQ:AKBA)

8.13
Delayed Data
As of May 22
 -0.01 / -0.12%
Today’s Change
7.27
Today|||52-Week Range
31.00
-30.15%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close8.14
Today’s open8.09
Day’s range7.95 - 8.16
Volume208,910
Average volume (3 months)332,437
Market cap$234.4M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-513.74%
Earnings growth (this year)+98.35%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
STMLStemline Therapeutic...-0.20-1.51%
----
MSLIMerus Labs Internati...-0.12-4.88%
OCATOcata Therapeutics I...+0.11+1.66%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$0.00
Annual profit (last year)-$37.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John P. Butler
CFO, Treasurer, SVP &
Head-Investor Relations
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers